Fisioterapia Respiratória
Análise Rasch | Desenvolvimento e validação do questionário de impacto dos sintomas para Covid longa (symptom burden questionnaire for long covid – SBQ-LC).
29 Abr, 2022 | 15:15h
Comentário no Twitter
New research developed and validated a symptom burden questionnaire for long covid which has the potential to benefit international clinical trials and inform clinical management https://t.co/akrRleap0W
— The BMJ (@bmj_latest) April 27, 2022
Sintomas persistentes de COVID-19 em estudo comunitário de 606.434 pessoas na Inglaterra.
27 Abr, 2022 | 16:41h
Comentário no Twitter
Thirty-eight percent of participants from a community-based study of symptoms following COVID-19 reported persistent symptoms that lasted 12 weeks or more, according to an article published in @NatureComms. https://t.co/sAEutdOkSS pic.twitter.com/oCyyXGIRbk
— Nature Portfolio (@NaturePortfolio) April 20, 2022
Covid-19: estudo mostra que somente 1/4 dos pacientes admitidos em hospital sentem-se completamente recuperados após 1 ano.
27 Abr, 2022 | 16:39hComentário convidado: Long COVID: systemic inflammation and obesity as therapeutic targets – The Lancet Respiratory Medicine
Comentário no Twitter (fio – clique para saber mais)
PHOSP-COVID study:
– 232 (29%) of 804 pts fully recovered at 1y
– Female sex, obesity, & IMV = less likely to feel fully recovered
– inflamm mediators📈in those w/ most severe physical, mental health, & cognitive impairmentsRead it here: https://t.co/rVZuVDo4xl
— The Lancet Respiratory Medicine (@LancetRespirMed) April 25, 2022
Seguimento de 1 ano de estudo randomizado | Em pacientes em UTI com hipoxemia grave, não houve diferença na mortalidade de longo prazo e na qualidade de vida relacionada à saúde com alvos de oxigenação mais baixos vs. mais altos.
25 Abr, 2022 | 12:42hEstudo original: Lower or Higher Oxygenation Targets for Acute Hypoxemic Respiratory Failure – New England Journal of Medicine
Comentário no Twitter
Lower (8 kPa) vs higher oxygenation (12 kPa) targets: no longterm survival benefit nor HRQoL improvement at 1y in #ICU pts with severe hypoxaemia (HOT-ICU trial cohort). Substantial impairments in several EQ-5D-5L dimensions in survivors in both groups.
🖇️ https://t.co/P48Cd5sIWK pic.twitter.com/JBFEIqDdcB— Intensive Care Medicine (@yourICM) April 20, 2022
Estudo controlado não randomizado: posição prona em paciente não intubado (média de 4,2 horas/dia) pode não ser benéfica para adultos internados com Covid-19.
21 Abr, 2022 | 12:29hComentários:
Study suggests worse outcomes for awake COVID patients in prone position – CIDRAP
Putting Hospitalized COVID Patients on Their Belly May Not Be a Good Idea After All – HealthDay
Conteúdos relacionados:
RCT: Prone positioning of patients with moderate hypoxia due to COVID-19 – medRxiv
Comentário no Twitter (fio – clique para saber mais)
Important negative study: non randomized trial finds no clinical benefit to awake proning vs usual care in COVID
No difference in rates of intubation, length of stay, or 28 day mortality
Medicine is humbling. This emphasizes the importance of trials
📄https://t.co/ksh9Ic9XBL
1/ pic.twitter.com/sjHHv4WQs8— Nick Mark MD (@nickmmark) April 18, 2022
M-A | Prevalência global da condição pós-COVID-19 ou COVID longa.
21 Abr, 2022 | 11:37hComentário: Global data reveal half may have long COVID 4 months on – CIDRAP
Comentário no Twitter (fio – clique para saber mais)
🚨The so far largest meta-analysis of more than 1.5 million infected individuals puts the global prevalence of #LongCovid at 43%. Some additional key findings. 🧵https://t.co/XGu23MV3Ra
1/— Jonas R. Kunst (@KunstJonas) April 17, 2022
M-A | Metas de oxigênio durante a ventilação mecânica na UTI.
12 Abr, 2022 | 12:20hConsenso: COVID longa em crianças.
11 Abr, 2022 | 12:57hConteúdos relacionados:
First research definition for ‘Long COVID’ in kids and young people formally agreed.
Editorial | Long covid in children and adolescents – “Risk appears low, but many questions remain”.
Review: Long COVID symptoms in children rarely persist beyond three months.
Perspectiva | Como estudar a COVID longa grave para compreender os distúrbios pós-infecciosos além da COVID-19.
8 Abr, 2022 | 21:42hStudying severe long COVID to understand post-infectious disorders beyond COVID-19 – Nature Medicine
Conteúdos relacionados:
Review: Post-acute COVID-19 syndrome.
ESCMID rapid guidelines for assessment and management of long COVID.
ERS statement on Long COVID-19 follow-up.
Proposed subtypes of long-Covid and their respective potential therapies.
EuGMS Guidance: Management of post-acute COVID-19 patients in geriatric rehabilitation.
Addressing Post-COVID Symptoms: A Guide for Primary Care Physicians.
Update to post-acute sequelae of SARS-CoV-2 infection: Caring for the ‘long-haulers’.
Systematic Review: Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection.
WHO Consensus: A clinical case definition of post COVID-19 condition (Long Covid).
Characterizing long COVID: a living systematic review.
Long Covid – The illness narratives.
New guidelines to help doctors manage long COVID patients published.
M-A: More than 50 long-term effects of COVID-19. (vários artigos sobre o tema)
Review | Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus.
The pathogenesis and long-term consequences of Covid-19 cardiac injury: state-of-the-art review.
COVID-19 infections increase risk of heart conditions up to a year later, study finds.
Comentário do autor no Twitter (fio – clique para saber mais)
1/ HGE (https://t.co/VMUVMAo1bJ) position paper on #LongCOVID #PACS . By focusing on the most severe patients, w severe organ damage/dysfunction following mild/moderate #COVID19 – we will search for genetic and immunological mechanisms of disease https://t.co/dZQPEoNkhl pic.twitter.com/tgblk7oFQG
— Petter Brodin (@BrodinPetter) April 5, 2022


